Markus Mezger

9PUBLICATIONS
14CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 23, 2024
Accelerated generation of gene-engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9.

Justin S Antony, Anabel Migenda Herranz, Tahereh Mohammadian Gol

|Nov 25, 2023
CRISPR-Cas9-Based Gene Knockout of Immune Checkpoints in Expanded NK Cells.

Tahereh Mohammadian Gol, Miso Kim, Ralph Sinn

|Jan 20, 2023
Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies.

Guillermo Ureña-Bailén, Milena Block, Tommaso Grandi

|Dec 23, 2022
Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.

Yujuan Hou, Guillermo Ureña-Bailén, Tahereh Mohammadian Gol

|Nov 11, 2022
Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.

Guillermo Ureña-Bailén, Jérôme-Maurice Dobrowolski, Yujuan Hou

|Jan 21, 2022
Somatic Reversion of a Novel <i>IL2RG</i> Mutation Resulting in Atypical X-Linked Combined Immunodeficiency.

Yujuan Hou, Hans Peter Gratz, Guillermo Ureña-Bailén

Pageof 2

Frequent Collaborators

3 joint publications

Guillermo Ureña-Bailén

3 joint publications

Alicia Roig-Merino

1 joint publications

Ekkehard Sturm

1 joint publications

Karin Melanie Cabanillas Stanchi